PRKCI and colorectal cancer: Previous studies have indicated that novel aPKC inhibitors ICA-1S and ζ-Stat (Figure 1) decreased the migratory behaviors of colorectal cancer cells and were selective for PKC-ι/λ and PKC-ζ, respectively (16, 19).